Nanospectra Biosciences
Show contact
Michael Brawer is Internationally recognized expert is prostate cancer and urology. Responsible for leading overall clinical development, regulatory, and medical affairs activities.
David Jorden
CEO & Director
Michael Brawer
Chief Medical Officer
Glenn P. Goodrich
COO & VP, Process Development & Chemistry
3 members
Current role
View in org chart